What is the NOAEL for Methyleugenol?
Methyleugenol has 62 NOAEL studies in the database. The lowest reported value is cancer listing type. Source: California Proposition 65.
Also known as: Benzene, 1,2-dimethoxy-4-(2-propenyl)-, 4-Allyl-1,2-dimethoxybenzene, BRN 1910871, Caswell No. 579AB, 1,2-Dimethoxy-4-(2-propen-1-yl)benzene (+6 more)
CAS 93-15-2
Methyleugenol (CAS 93-15-2) is a chemical substance; key hazard signal: IARC Group 2A. Key regulatory status: California Proposition 65, REACH registered, 8 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, IARC, ECHA REACH, CA Prop 65, EPA TRI.
Methyleugenol is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H317, H341, H351, H350, H316, H320, H373).
CAS, identifiers, formula, and alternate names for the matched substance record.
Carcinogenic hazard classification from IARC monograph evaluations.
| Group | Meaning | Evaluated | Volume |
|---|---|---|---|
| Group 2A | Probably carcinogenic | 2023 | 101, 134 |
California OEHHA listing status and toxicity category.
| Chemical | Toxicity Type | Cancer | Developmental | Listed |
|---|---|---|---|---|
| - | cancer | Yes | No | - |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Europe; Personal care; restricted | European Commission | CosIng |
| IFRA Transparency | IFRA | IFRA |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| active_ingredient; Pesticides | California Department of Pesticide Regulation | State of California |
| active_ingredient; Australia | Australian Pesticides and Veterinary Medicines Authority | CPCat |
| detected; Europe; Personal care - make-up and related | Danish Environmental Protection Agency | Danish EPA |
| OEHHA Proposition 65 (3/2019) | STATE OF CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY | OEHHA Proposition 65 List |
| OEHHA Proposition 65 (1/2023) | California Office of Environmental Health Hazard Assessment | OEHHA Proposition 65 List |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| 26.56 | uL/min/10^6 cells | Clint | - | Human | NTP_ICE_adme_parameters |
| =9.87 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 4 | unitless | EPA Classification | Ocular | Rabbit | NTP_ICE_eye_irritation |
| 4 | unitless | EPA classification | Dermal | Rat | NTP_ICE_acute_dermal |
| =4 | Unitless | EPA classification | oral | Rat (Female) | NTP_ICE_acute_oral |
| 4 | unitless | EPA classification | Dermal | Rabbit | NTP_ICE_skin_irritation |
| 29T9VA6R7M | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 29T9VA6R7M | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 29T9VA6R7M | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 29T9VA6R7M | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0.1416 | fraction | Fu | - | Human | NTP_ICE_adme_parameters |
| 5 | unitless | GHS classification | Dermal | Rat | NTP_ICE_acute_dermal |
| =5 | Unitless | GHS classification | oral | Rat (Female) | NTP_ICE_acute_oral |
| 2A | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 2 | unitless | IARC group | - | - | NTP_ICE_cancer |
| - | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 5184 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| >4.8 | mg/L | LC50 | Inhalation | - | NTP_ICE_acute_inhalation |
| >5000 | mg/kg | LD50 | Dermal | Rat | NTP_ICE_acute_dermal |
| >5000 | mg/kg bw | LD50 | oral | Rat (Female) | NTP_ICE_acute_oral |
| =10 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =30 | mg/kg bw/day | LEL | oral | Mouse | ToxValDB_ToxRefDB |
| =30 | mg/kg bw/day | LEL | oral | mouse (b6c3f1; B6C3F1) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =37 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| 10 | mg/kg bw/day | LOAEL | oral | rat | COSMOS_DB |
| 30 | mg/kg bw/day | LOAEL | oral | mouse | COSMOS_DB |
| =75 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ToxRefDB |
| =75 | mg/kg bw/day | LOAEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =80 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =300 | mg/kg bw/day | LOAEL | oral | Mouse | ToxValDB_ToxRefDB |
| =300 | mg/kg bw/day | LOAEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =9 | mg/kg bw/day | LOEL | oral | Mouse | ToxValDB_ECOTOX |
| =37 | mg/kg bw/day | LOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =37 | mg/kg bw/day | LOEL | oral | Rat | ToxValDB_ECOTOX |
| =100 | mg/kg bw/day | LOEL | injection | Rat | ToxValDB_ECOTOX |
| =300 | mg/kg bw/day | LOEL | oral | Rat | ToxValDB_ECOTOX |
| - | unitless | Model Score | - | - | NTP_ICE_endocrine |
| >- | mg/kg bw/day | NEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =10 | mg/kg bw/day | NEL | oral | mouse (b6c3f1; B6C3F1) | ToxRefDB_ToxRefDB_v3_pod.csv |
| 10 | mg/kg bw/day | NOAEL | oral | mouse | COSMOS_DB |
| 18 | mg/kg bw/day | NOAEL | oral | rat | COSMOS_DB |
| 30 | mg/kg bw/day | NOAEL | oral | rat | COSMOS_DB |
| 37 | mg/kg bw/day | NOAEL | oral | rat | COSMOS_DB |
| =100 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ToxRefDB |
| =100 | mg/kg bw/day | NOAEL | oral | rat (fischer; Fischer 344) | ToxRefDB_ToxRefDB_v3_pod.csv |
| 300 | mg/kg bw/day | NOAEL | oral | mouse | COSMOS_DB |
Showing 50 of 62 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 4-allylveratrole | 202-223-0 | ECHA overview → |
TRI hazard and reporting flags for the matched chemical.
| Chemical | Category | Flags |
|---|---|---|
| Methyleugenol | - | - |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
1 food-safety record found.
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Methyleugenol has 62 NOAEL studies in the database. The lowest reported value is cancer listing type. Source: California Proposition 65.
Methyleugenol appears on 8 regulatory/inventory lists including Europe; Personal care; restricted, IFRA Transparency, food_additive; Substances Added to Food (formerly EAFUS) (2/2019), and 5 more. Source: EPA CPDat.
Methyleugenol is classified by IARC as Group 2A — probably carcinogenic to humans (evaluated 2023). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
Yes, Methyleugenol is listed under California Proposition 65 for cancer. Source: California OEHHA Proposition 65.
Yes, Methyleugenol is also indexed as a cosmetic ingredient under the name Methyl Eugenol. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, IARC Monographs, ECHA REACH, California Proposition 65, EPA Toxics Release Inventory, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Methyleugenol is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H317, H341, H351, H350, H316, H320, H373).
Methyleugenol also appears in cosmetics, pharmaceutical, food safety, cannabis databases.